Nuveen Asset Management, LLC - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 108 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 4.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$947,618
+12.4%
80,443
+13.2%
0.00%
Q1 2024$842,855
-3.2%
71,0670.0%0.00%
Q4 2023$870,572
+48.3%
71,067
+16.6%
0.00%
Q3 2023$586,968
+5.6%
60,952
-1.3%
0.00%
Q2 2023$556,047
+114548.9%
61,7830.0%0.00%
Q1 2023$485
-50.6%
61,783
-10.4%
0.00%
Q4 2022$982
-99.9%
68,946
-13.6%
0.00%
Q3 2022$1,158,000
+48.7%
79,778
+0.7%
0.00%
Q2 2022$779,000
-19.0%
79,243
+24.0%
0.00%
Q1 2022$962,000
+20.9%
63,905
+1.3%
0.00%
Q4 2021$796,000
-66.1%
63,100
-48.3%
0.00%
-100.0%
Q3 2021$2,351,000
-19.8%
122,122
-0.2%
0.00%0.0%
Q2 2021$2,932,000
+126.1%
122,359
+47.3%
0.00%
Q1 2021$1,297,000
-18.5%
83,090
-0.9%
0.00%
-100.0%
Q4 2020$1,592,000
+14.1%
83,838
-24.3%
0.00%0.0%
Q3 2020$1,395,000
+4.3%
110,791
+0.2%
0.00%0.0%
Q2 2020$1,338,000
+209.0%
110,535
+95.0%
0.00%
Q1 2020$433,000
-38.4%
56,672
+43.5%
0.00%
Q4 2019$703,000
+88.0%
39,479
+22.6%
0.00%
Q3 2019$374,000
-72.7%
32,200
-48.0%
0.00%
-100.0%
Q2 2019$1,372,00061,9060.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SV Health Investors, LLC 2,579,490$20,146,00022.25%
Novo Holdings A/S 2,901,927$22,664,0002.41%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 322,436$2,518,0000.96%
Vivo Capital, LLC 300,325$2,346,0000.69%
VHCP Management II, LLC 221,651$1,635,0000.67%
RA Capital Management 591,070$4,616,0000.57%
INTERWEST VENTURE MANAGEMENT CO 329,942$2,577,0000.55%
Eventide Asset Management 98,100$766,0000.05%
BOOTHBAY FUND MANAGEMENT, LLC 21,665$169,0000.03%
A.R.T. Advisors, LLC 11,116$86,0000.00%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders